Impax Laboratories, Inc. (Nasdaq: IPXL) provided an update and additional information to patients, physicians and customers on its epinephrine injection ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE